The global Recombinant DNA Technology market was valued at US$ 505 million in 2022 and is projected to reach US$ 653.1 million by 2029, at a CAGR of 3.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Recombinant DNA Technology market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Technology. This report contains market size and forecasts of Recombinant DNA Technology in global, including the following market information:
- Global Recombinant DNA Technology Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Therapeutic Agent Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant DNA Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant DNA Technology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant DNA Technology Market Segment Percentages, by Type, 2022 (%)
- Therapeutic Agent
- Vaccine
- Biotech Crops
- Specialty Chemicals
Global Recombinant DNA Technology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant DNA Technology Market Segment Percentages, by Application, 2022 (%)
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Others
Global Recombinant DNA Technology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant DNA Technology Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Recombinant DNA Technology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Recombinant DNA Technology revenues share in global market, 2022 (%)
key players include:
- Monsanto Company
- Roche
- Biogen
- Amgen
- Novartis
- Eli Lilly and Company
- GenScript
- Pfizer Inc.
- Novo Nordisk
- Sanofi
- Merck KGaA
- Profacgen
- Biocon
- GlaxoSmithKline
- Cibus
- Horizon Discovery Group
- New England Biolabs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant DNA Technology, market overview.
Chapter 2: Global Recombinant DNA Technology market size in revenue.
Chapter 3: Detailed analysis of Recombinant DNA Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant DNA Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
